Abingdon Health (LON:ABDX) Posts Quarterly Earnings Results

Abingdon Health (LON:ABDX) posted its quarterly earnings results on Tuesday. The company reported GBX (0.51) earnings per share for the quarter, Digital Look Earnings reports. Abingdon Health had a negative net margin of 33.88% and a negative return on equity of 55.91%.

Abingdon Health Trading Down 8.9%

ABDX traded down GBX 0.85 during trading hours on Wednesday, reaching GBX 8.65. The company’s stock had a trading volume of 350,495 shares, compared to its average volume of 236,617. The stock has a market cap of £21.86 million, a PE ratio of -10.68 and a beta of 0.13. Abingdon Health has a fifty-two week low of GBX 5.50 and a fifty-two week high of GBX 13. The company has a debt-to-equity ratio of 15.05, a current ratio of 1.91 and a quick ratio of 1.96. The business’s 50-day moving average is GBX 10.74 and its 200-day moving average is GBX 10.52.

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.